Attapon Cheepsattayakorn1,2*, Ruangrong Cheepsattayakorn3 and Utoomporn Sittisingh2
110th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand
2St. Theresa International College, Nakorn Nayok, Thailand
3Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
*Corresponding Author: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, Changklan, Muang, Chiang Mai, Thailand.
Received: May 26, 2020; Published: June 01, 2020
Coronaviruses and influenza viruses, the pandemic viruses can cause acute respiratory distress syndrome (ARDS) contributing to lethally acute lung injuries (ALI) and death. Activation of nuclear factor erythroid 2 (nfe2)-related factor 2 (nrf2), a major regulator of antioxidant response element (ARE)-driven cytoprotective protein expression plays an critical role in preventing cells and tissues from oxidative-stress-induced injury. Both viral and bacterial infections can contribute to cytokine storm that results in increased oxidative stress. Vitamin C is beneficial to critical care management due to its important component of the cellular antioxidant system.
Citation: Attapon Cheepsattayakorn., et al. “Intravenous High-Dose and Supplementation of Vitamin C Can Effectively Prevent and Treat COVID-19?".Acta Scientific Pharmaceutical Sciences 4.7 (2020): 01-02.
Copyright: © 2020 Attapon Cheepsattayakorn., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.